Stroke and Vascular Neurology

Papers
(The TQCC of Stroke and Vascular Neurology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial215
Updates on vascular dementia70
Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial48
Treating acute large vessel occlusion stroke: to bridge or not to bridge?47
Chinese stroke association guidelines on reperfusion therapy for acute ischaemic stroke 202444
Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study37
Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOto35
Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebr29
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage29
Association ofAPOEgenotype with CT markers of cerebral amyloid angiopathy in spontaneous intracerebral haemorrhage28
Photochemically induced thalamus infarction impairs cognition in a mouse model26
Real-world evaluation of Brainomix e-Stroke software25
Mass effect, aneurysms and flow diverters: Is the pipeline embolization device the Lone Virtuoso? Commentary on ‘Pipeline embolization device for intracranial aneurysms presenting with mass effect: a 23
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study22
Quantitative angiographic haemodynamic evaluation of bypasses for complex aneurysms: a preliminary study22
Stenting for symptomatic intracranial arterial stenosis with different qualifying arteries: a preplanned pooled individual patient data analysis21
Definitions of white matter hyperintensity change: impact on estimates of progression and regression21
Vascular dementia has the highest hospitalisation rate in China: a nationwide hospital information system study21
Intelligent cholinergic white matter pathways algorithm based on U-net reflects cognitive impairment in patients with silent cerebrovascular disease21
Treatment practice of vasospasm during endovascular thrombectomy: an international survey20
Discrepancies between clinical and autopsy findings in patients who had an acute stroke19
ADVISING score: a reliable grading scale based on injury and response for intracerebral haemorrhage19
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications19
Analytical validation of GMEX rapid point-of-careCYP2C19genotyping system for the CHANCE-2 trial18
Trendelenburg position for acute anterior circulation ischaemic stroke with large artery atherosclerosis aetiology (HOPES 3): rationale and design18
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study18
Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk18
Development of a deep learning method to identify acute ischaemic stroke lesions on brain CT18
Gut Microbiome and Stroke: a Bidirectional Mendelian Randomisation Study in East Asian and European Populations18
Clinical imaging factors of excellent outcome after thrombolysis in large-vessel stroke: a THRACE subgroup analysis17
Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests17
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease17
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry16
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications16
Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design16
Remote ischaemic conditioning for stroke: unanswered questions and future directions15
Magnitude of systolic blood pressure reduction following endovascular treatment and clinical outcomes in acute large artery occlusion stroke15
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP14
Haemorrhage risk of brain arteriovenous malformation during pregnancy and puerperium14
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model14
Associations of HDL-C/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: a longitudinal study based on 384 093 participants from the UK Biobank14
Cerebral venous sinus thrombosis: changing trends in the incidence, age and gender (findings from the CMC Vellore CVT registry)14
Effects and safety of aspirin use in patients after cerebrovascular bypass procedures14
Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease14
Response to ‘comments on the article ‘sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections’’13
Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage12
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial12
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial11
Efficacy and safety of a neurointerventional operation robotic assistance system in cerebral angiography11
Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries11
Early cisternal fibrinolysis is more effective than rescue spasmolysis for the prevention of delayed infarction after subarachnoid haemorrhage11
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–202011
Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)11
Functional status at 30 and 90 days after mild ischaemic stroke11
Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset: a prospective cohort study10
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats10
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations10
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial10
Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis10
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction10
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)9
When treating acute ischaemic stroke of LVO type, time window prevails over tissue window9
New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-19
Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea9
Association of fluid-attenuated inversion recovery vascular hyperintensity with ischaemic events in internal carotid artery or middle cerebral artery occlusion9
Editorial: minor stroke is not minor8
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke8
Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial8
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial8
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway8
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISR8
In patients who had a stroke or TIA, enlarged perivascular spaces in basal ganglia may cause future haemorrhagic strokes8
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel8
Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland8
A Mendelian randomisation, propensity score matching study to investigate causal association between serum homocysteine and intracranial aneurysm8
Understanding external carotid artery collateralisation after cerebral revascularisation in moyamoya disease: insights from quantitative analysis8
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 20188
Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity7
Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms7
Asymptomatic carotid artery stenosis is associated with increased Alzheimer’s disease and non-Alzheimer’s disease dementia risk7
Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials7
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study7
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis7
Penumbra-targeted CircOGDH siRNA-loaded nanoparticles alleviate neuronal apoptosis in focal brain ischaemia7
CSA declaration of next-generation reperfusion therapy for ischaemic stroke7
Association between coexisting intracranial artery and extracranial carotid artery atherosclerotic diseases and ipsilateral cerebral infarction: a Chinese Atherosclerosis Risk Evaluation (CARE-II) stu7
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms7
Night-time diastolic blood pressure variability relates to stroke recurrence in patients who had ischaemic stroke with small artery occlusion7
White matter disease derived from vascular and demyelinating origins7
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial7
Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk7
Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial7
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study7
0.27454590797424